http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-344357-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N53-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N53-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N53-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-80
filingDate 1967-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-344357-A1
titleOfInvention A PROCEDURE TO PREPARE CYCLOPROPANOCARBOXYLATES.
abstract Novel substituted phthalans of the formula <FORM:1117625/C2/1> where R is a di-C1- 6 alkylamino-C1- 6 alkyl radical, an amino-C1- 6 alkyl radical, a mono-C1- 6 alkylamino-C1- 6 alkyl radical or a group comprising a heterocyclic ring linked via a N atom to a C1- 6 alkyl attached to the phthalan nucleus, and each R1 represents H or each R1 represents an alkyl, aryl, aralkyl or heterocyclic radical, are obtained (a) by treating a substituted phthalan of the formula <FORM:1117625/C2/2> in which R1 is H, with a mineral acid to form the acid addition salt and subsequently heating the salt in the presence of p-toluene sulphonic acid as a melt to form the desired phthalan in which each R1 is H or (b) by treating the corresponding phthalan II in which each R1 is an alkyl, aryl, aralkyl or heterocyclic radical with a mineral acid to form the desired substituted phthalan. Pharmaceutical compositions, having anti-inflammatory, diuretic and analgesic activity, comprise compounds of Formula (I), either as free bases or in the form of non-toxic pharmaceutically acceptable acid addition salts or quaternary ammonium salts, together with pharmaceutical diluents or carriers in dosage forms such as tablets, suspensions, solutions or suppositories.
priorityDate 1966-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414312058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511752

Total number of triples: 26.